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ABSTRACT  
Objectives: Infants of smoking (S) and substance misusing (SM) mothers have 
an increased risk of sudden infant death syndrome. The aim of this study was to 
test the hypothesis that infants of SM or S mothers compared to infants of non 
substance misusing, non-smoking mothers (controls) would have a poorer 
ventilatory response to hypoxia, which was particularly marked in the SM 
infants.                                                                                                       
Design:  Physiological study.                                                                        
Setting:  Tertiary perinatal centre.                                                                   
Patients: 21 SM; 21 S and 19 control infants. Infants were assessed before 
maternity/neonatal unit discharge.                                                       
Interventions:  Maternal and infant urine samples were tested for cotinine, 
cannabinoids, opiates, amphetamines, methadone, cocaine and benzodiazepines.            
Main out come measures: During quiet sleep, the infants were switched from 
breathing room air to 15% oxygen and changes in minute volume were 
assessed.                                                                                                    
Results: The SM infants had a greater mean increase (p=0.028, p= 0.034 
respectively) and a greater magnitude of decline (p<0.001, p=0.018 
respectively) in minute volume than the S infants and the controls.  The rate of 
decline in minute volume was greater in the SM infants (p=0.008) and the S 
infants (p=0.011) compared to the controls.                                           
Conclusions:  Both antenatal substance misuse and smoking affect the infant’s 
ventilatory response to a hypoxic challenge. 
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INTRODUCTION  
Substance misuse during pregnancy is common. A survey carried out by the 
Office for National Statistics showed that approximately one in a thousand 
women in Great Britain were dependent on opioids, the majority were of child 
bearing age. Anonymous screening of urine samples from women attending 
antenatal clinics in south London, demonstrated approximately 16% of the 807 
mothers screened were taking at least one illicit substance.[1] In utero exposure 
to illicit drugs such as opioids, marijuana and cocaine is associated with an 
increased risk of sudden infant death syndrome (SIDS).[2] In a population based 
study, a seven fold increased risk of SIDS was reported amongst infants of 
substance using mothers.[2]  
 
Globally, there has been a significant decline in maternal smoking during 
pregnancy. Across the UK, the percentage of mothers smoking before or during 
pregnancy fell from 33 percent to 26 percent between 2005 and 2010.  A 
smaller percentage of all mothers smoked throughout pregnancy in 2010 (12 
percent compared to 17 percent in 2005).[3] Nevertheless, maternal smoking in 
pregnancy remains an important problem, as evidenced in a population based 
study by the percentage of mothers of SIDS victims who smoked during 
pregnancy that  increased from 57% in the 1980s to 86% in 2003.[4]  
Furthermore, since the ‘back to sleep’ campaign, cigarette smoke exposure in 
utero is the leading independent risk factor for the occurrence of SIDS.[5] The 
increased risk of SIDS of infants whose mother smoked during pregnancy has 
been reported to between two to four fold but, if combined with other risk 
factors, as high as six fold.[5-7]  Over 60 studies have examined the relation 
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between maternal smoking during pregnancy and risk of SIDS.  The pooled 
relative risk associated with maternal smoking was RR=2.86 (95% CI=2.77, 
2.95).[8] 
 
A possible explanation for the increased SIDS risk is that infants of SM or S 
mothers may have abnormalities of respiratory control.  There is a body of 
evidence demonstrating nicotine exposure could and does influence respiratory 
control in animal models.  For example, prenatal exposure to nicotine may alter 
the function of peripheral chemoreceptors, as in three-day old rabbit pups 
exposure to nicotine was associated with reduced dopamine levels and increased 
expression of tyrosine hydroxylase in the carotid bodies.[9]  The ventilatory 
responses to hypoxia has been demonstrated to be attenuated by infusion of 
nicotine to 7, 17 and 27 day old lambs.[10]  Furthermore, nicotine infusion to 
pregnant rats throughout gestation resulted in the pups having suppressed 
noradrenergic neuronal activity in the brainstem and forebrain and 
hyperresponsiveness to hypoxia.[11]  In addition, intermittent hypoxia was 
demonstrated to result in transient delay in neuronal migration early in the 
postpartum period in Spragne-Dawley rats, amplified by concurrent nicotine 
administration.[12] Data from in vivo studies have highlighted that in utero 
exposure to substance misuse may also affect respiratory control.  Infants 
prenatally exposed to cocaine were demonstrated to have a higher incidence of 
cardiorespiratory pattern abnormalities than infants with no prenatal drug 
exposure.[13] In another study, full term infants prenatally exposed to cocaine 
and opiates had less periodic breathing.[14] In addition, comparison of infants of 
substance misusing mothers to controls demonstrated the former group were 
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relatively insensitive to a carbon dioxide challenge.[15] Even apparently 
asymptomatic neonates with a maternal history of cocaine use may have 
degenerative changes or focal infarctions in their basal ganglia.[16] We, 
therefore, hypothesised that infants of mothers who smoked and/or substance 
misused during pregnancy would have a poor ventilatory response to hypoxia.  
The aim of this study was to test that hypothesis by comparing the ventilatory 
responses to hypoxia of infants of substance misusing mothers, infants of 
smoking mothers and infants of non-substance misusing, non-smoking mothers.  
In addition, we tested a further hypothesis that any change in the ventilatory 
response to hypoxia would be greater in newborns of mothers who substance 
misused, as such mothers usually also smoke, compared to those whose 
mothers had only smoked. 
 
METHODS   
Infants were eligible for entry into the study if they were born at 36 weeks of 
gestational age or greater at King’s College Hospital NHS Foundation Trust and 
had no congenital abnormalities. Informed written parental consent was 
obtained and the study was approved by the Guy’s and St Thomas’s Hospitals 
NHS Foundation Trust Research Ethics Committee.   
Three groups were recruited: 
1. Infants of mothers who gave on antenatal screening a history of 
substance misuse during pregnancy (SM infants). 
2. Infants of mothers who gave on antenatal screening a history of smoking 
during pregnancy (S infants).  
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3. Infants of mothers who neither smoked nor misused substances during 
pregnancy (controls). 
 
Smoking was defined as any history of daily smoking regardless of the number 
of cigarettes smoked/day.  Substance misuse was defined as use of any of the 
illicit drugs at any stage during pregnancy; mothers were enrolled from a 
methadone programme in a dedicated antenatal substance misuse clinic.    
 
Hypoxic challenge  
Physiological measurements were carried out when the infants were in quiet 
sleep.  Sleep state was determined by observation of the behavioural state.[17] 
An infant was defined as being in quiet sleep when their eyes were closed, with 
no body or eye movement, no vocalization and their respiratory rate was 
regular.  The hypoxic challenge was delivered via a facemask and custom-made 
open circuit system using 15% oxygen in balanced nitrogen from a cylinder 
(BOC Gases, UK). The facemask was placed over the infant’s mouth and nose, 
therapeutic putty was put around the rim of the facemask to ensure an airtight 
seal around the face. Respiratory flow was measured using an appropriately 
sized pneumotachograph connected to the face mask (Mercury F10L, G M 
Instruments, Kilwinning, Scotland) with a dead space 0.8 ml and a resistance of 
1.4 cmH2O/L/second.  The distal end of the pneumotachograph was connected to 
a two-way non-rebreathing valve contained within the open circuit system.  A 
constant flow of medical air from a cylinder (BOC Gases, UK) was delivered to 
the inspiratory port of the two-way non-rebreathing valve via length of wide 
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bore (20mm), low resistance tubing. The pneumotachograph was attached to a 
differential pressure transducer/amplifier (13-4615-70, Gould, Cleveland OH, 
USA).  Data were acquired and displayed in real time on a PC computer running 
Spectra software (Grove Medical, London, UK) with 100 Hz analog to digital 
sampling (PCI-MIO-16XE-50, National Instruments, Austin TX, USA).  
Respiratory rate, inspiratory time and the time to peak tidal expiratory flow were 
determined from the flow signal.  Tidal volume was determined by digital 
integration of the flow signal by the acquisition software. Minute ventilation was 
calculated from the infant’s respiratory rate and tidal volume and related to the 
infant’s weight as maternal smoking and substance misuse are known to affect 
birth weight.  Inspired and expired gases were sampled continuously using a 
small cannula inserted through the facemask and positioned close to the infant's 
mouth.  The side stream method was used to measure carbon dioxide (CO2) 
levels using a CO2 sampling line and capnograph.  The maximum ETCO2 levels 
from the 60 second period immediately before the hypoxia challenge are 
reported.  Oxygen saturation was measured using a pulse oximeter (Masimo 
rainbow SET Pulse Oximetry). 
 
During quiet breathing, the infants were switched from breathing room air to 
15% oxygen in nitrogen (BOC Gases, UK). The final minute of tidal breathing in 
air was used as the baseline value. The hypoxic challenge was maintained for 
five minutes, but terminated if the oxygen saturation level fell below 85%. 
Infants respond to hypoxia with a biphasic response [18] .   The responses to 
the hypoxic challenge were determined by   
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1) The magnitude of increase in minute ventilation from baseline to the 
peak ventilation 
2) The magnitude of  decline in minute volume from the peak to the lowest 
minute volume  
3) The rate of decline in minute volume, calculated as the peak minute 
volume-lowest minute volume divided by the time from peak to the 
lowest minute volume.  
4) The change in the oxygen saturation level from baseline to the lowest 
oxygen saturation level. 
 
The time to peak minute ventilation was noted, as was the time to the lowest 
SaO2 and the baseline end tidal CO2. 
 
Assessment of exposure to smoking and substance misuse 
In the immediate postpartum period, urine samples were obtained from all 
mothers and infants to assess the profile of maternal substance misuse and for 
cotinine analysis.  Urine samples were also obtained from the SM mothers during 
their antenatal out-patient attendance. The urine cotinine results for both 
maternal and infant urine samples were divided into categories: <10ng/ml, 10-
500ng/ml and > 500ng/ml. The methadone doses used during pregnancy were 
obtained from the medical records for mothers prescribed methadone.  
Screening was carried out for cannabinoids, opiates, amphetamines, methadone, 
cocaine and benzodiazepines as previously described.[19]   
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Analysis 
Differences between the three groups for continuous data were assessed for 
statistical significance using multiple regression where possible, with data 
transformation as needed to meet normality assumptions, if that was not 
possible the Kruskal-Wallis analysis of ranks test was used. Proportions were 
compared between groups using chi-squared test or Fisher’s Exact test where 
the numbers in each group were small.  Differences in baseline minute volume, 
the increase and decrease in minute volume were adjusted for gestational age 
using multiple regression on the transformed outcomes. Adjusted means and 
95% confidence intervals are presented.  The increase in minute volume data 
were highly skewed and so a square root transformation was required to satisfy 
Normality assumptions.[20] Since back-transformed confidence intervals are 
non-interpretable for square root-transformed data, p values are reported using 
the transformed data for rigour, but means and confidence intervals are 
presented on the natural scale.  For data that could not be transformed, post hoc 
comparisons were conducted using the Mann Whitney-U test (continuous data) 
or Chi squared test (categorical data).  Where regression analysis was able to be 
used, post hoc comparisons were made using likelihood ratio tests.  Analysis was 
performed using Stata v11.  
 
Sample size 
Recruitment of 20 infants in each of the three groups allowed detection of a 
difference equivalent to one standard deviation in each outcome between the 
groups with 80% power at the 5% level. A similar magnitude of difference had 
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been detected in the ventilatory response to added dead space between 
newborns of smoking and non-smoking mothers.[21] 
 
RESULTS 
Twenty-one substance misuse (SM), 21 smoking (S) and 19 control infants were 
assessed (Table 1). The mean gestational age of the infants varied significantly 
between the three groups: SM infants were of significantly of lower mean 
gestational age than the S infants (37.3 vs 38.6; p=0.02) and the controls (37.3 
vs 38.8; p=0.007). Similarly mean birth weight varied significantly between 
groups, the mean birth weight of the SM infants was lower than that of the S 
infants (2536 vs 3106; p=0.02) and the controls (2536 vs 3291; p=0.003).  The 
urine analysis demonstrated that all the mothers of SM infants were also 
smoking, but that none of the mothers of the controls were smoking (Table 2). 
The urine analysis also demonstrated none of the mothers of S infants or the 
controls had been substance misusing.  There were no significant differences in 
the percentage of mothers or infants with cotinine levels in predefined categories 
between the S and SM groups (Table 2). Analysis of urine samples during 
antenatal out-patient attendances confirmed that all SM women were substance 
misusing and misusing a wide range of substances (Table 3).   In the SM group, 
urine analysis in the immediate post partum period demonstrated five of the 10 
women who had been prescribed methadone were also taking it illicitly.  
 
There was significant variability between the groups in mean baseline minute 
volume, which remained significant after adjustment for gestational age (Table 
4).  The SM infants had a significantly higher adjusted mean baseline minute 
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volume than controls (395 vs 348; p=0.005) (Table 4).  The initial increase in 
minute volume during the hypoxic challenge differed significantly between the 
groups before and after adjustment for gestational age, there was a significantly 
higher mean increase in the SM group compared to the S group (117 vs 57; 
p=0.028) and the controls (p=0.034) (Table 4). The magnitude of the 
subsequent decline in minute volume varied significantly between the groups 
with a greater magnitude of decline occurring in the SM compared to the 
controls (220 vs 106; p<0.001) and the S infants (220 vs 151; p=0.018).   The 
mean rate of decline in minute volume also varied significantly between the 
groups overall and was greater in the SM infants compared to the controls (4.29 
vs 160; p=0.008) and the S infants compared to the controls (4.29 vs 3.88; 
p=0.011) (Figure 1).  There were no significant differences in either the mean 
baseline oxygen saturation or mean lowest saturation level in response to the 
hypoxic challenge between the groups (Table 5).  The mean time to the lowest 
oxygen saturation, however, was greater in the controls compared to both the 
infants of S or SM mothers (115, 100, 100 seconds respectively; p=0.017) 
(Table 5).  There were no significant differences in the mean time of peak 
minute ventilation or the maximum baseline  end tidal CO2 levels between the 
three groups (Table 5).  It was noted, however, that the capnogram results 
often did not return to zero baseline on inspiration and this may have influenced 
some of our results.   
 
DISCUSSION  
 
We have demonstrated that infants of SM mothers had a greater magnitude of 
decline in ventilation than the controls and S infants and both the SM and S 
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infants had a greater rate of decline in minute ventilation compared to controls.  
The three groups’ gestational ages differed significantly and, as maturity at birth 
affects respiratory control, we adjusted for gestational age.  Similar significant 
differences were found after that adjustment.  Similarly, differences in the initial 
increase in minute ventilation between the three groups remarked significantly 
after adjustment for gestational age.  To our knowledge, this is the first study 
that has compared the responses to hypoxia in neonates of substance-
misuse/smoking mothers and smoking mothers.  Our results suggest in utero 
exposure to substance abuse and smoking have an additive effect on the 
response to a hypoxic challenge and may explain their increase risk of SIDS.  
The early excitatory phase of the biphasic ventilatory response to hypoxia is the 
result of peripheral chemoreceptor stimulation. It is mediated through N-methyl-
D-aspartate (NMDA) glutamate receptors in the caudal brainstem.  Prematurely 
born infants with neonatal apnoea were shown to have an increased ventilatory 
response to hypoxia.[22]  Reduction in arterial oxygen tension strongly 
stimulates the carotid bodies which mediate the rapid increase in ventilation.  
The authors [22], therefore, speculated that previous episodes of apnoea with 
resultant intermittent hypoxia led to the enhanced peripheral chemoreceptor 
response to hypoxia.  The peripheral chemoreptors are active from at least 28 
weeks of gestation.[23] Fetuses exposed to nicotine and other misused 
substances are exposed to intermittent/chronic hypoxia in utero which may 
explain the initial increased ventilatory response to hypoxia we document.[24]  
Our results demonstrating infants of misusing/smoking mothers had a greater 
initial increase in ventilation are supported by the finding that infants who were 
chronically exposed in utero to opiates had a significantly greater initial 
ventilatory increase to hypoxia compared to non-opiate exposed controls.[25] 
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Exposure to intermittent chronic hypoxia may explain our findings that, 
compared to controls, there was a greater rate of decline in the ventilatory 
response to the SM and S infants and a greater magnitude of decline in the SM 
infants.  In a piglet model, the decline was more marked following exposure to 
chronic intermittent hypoxia until day ten after birth [26] as evidenced by a 
decline in phrenic electroneurograms (ENGphr).   Several neurotransmitters 
including -aminobutyric acid (GABA) [27], adenosine [28, 29], serotoma [30] 
and opiods [31] are involved in the late component of the hypoxic ventilator 
response.  Intracisternal injection of bicuculline, a GABAA antagonist, in piglets 
aged two to ten days old reversed the effects of recurrent hypoxia on the 
ENGphr hypoxic response and eliminated apnoea during hypoxia.[26] The 
authors, therefore, speculated that in the newborn period, GABA is released 
within the brainstem in direct proportion to the number of episodes of recurrent 
hypoxia, resulting in activation of GABAA receptors and worsening of hypoxic 
respiratory depression.[26]  The late phase is mediated in part through platelet 
derived growth factor (PDGF) foreceptors maturation of the neuromodulators, 
particularly NMDA and PDGF-β Receptors mediated pathways occurs during the 
postnatal period.[30] 
 
Our study has strengths and some limitations.  We studied infants prior to 
maternity/neonatal unit discharge and thus were able to assess the effect of only 
the antenatal exposure to smoking and illicit substances.  We assessed 
substance misuse by analysing samples from the mothers and their infants and 
cotinine levels were also measured, hence we had objective evidence of 
substance misuse and antenatal smoking.   We were unable to assess the effect 
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of substance misuse alone as all the mothers from the substance-misuse group 
smoked.  In addition, we were unable to assess the effect of specific drug 
misuse as the majority of mothers were misusing multiple drugs. We did not find 
any significant differences between the groups in the lowest saturation level in 
response to the hypoxic challenge, but this is likely because we terminated the 
challenge if the oxygen saturation level fell below 85%.  The oxygen saturation 
level did not fall below 85% in all infants, hence we compared the time to the 
lowest oxygen saturation level in the three groups.  The time taken to reach the 
lowest SaO2 was significantly longer in the controls compared to either infants in 
the S or SM groups, likely reflecting the latter two groups had a greater 
magnitude of decline in ventilation than the controls.  We used a sidestream 
method to measure ETCO2 levels using a CO2 sampling line and capnograph.  
The sidestream method does not adequately monitor both nasal and oral airflow. 
When we examined the capnographic waves, it is often noted that capnogram 
trace did not return to zero baseline on inspiration which may have influenced 
some of our results. Given the method we used to measure ETCO2, it was not 
possible to evaluate the changes in ETCO2  at different periods during the hypoxic 
challenge. The differences in the maximum baseline ETCO2 levels were not 
statistically significant but there was a trend for the S infants to have lower 
levels than the controls and the SM infants lower levels than the S infants.  This 
trend likely reflects the significantly higher baseline minute volumes in the SM 
infants compared to the controls and the trend for the SM infants to have a 
higher baseline minute ventilation than the S infants and the S infants to have 
higher levels compared to the controls. The infants of substance misusing 
mothers had higher baseline minute ventilation than the other two groups, 
reflecting they were withdrawing from the substances their mothers had 
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misused.  Nevertheless, we were able to show a significant difference in the 
response of the SM infants to the hypoxic challenge compared to both the 
controls and the S infants.    
 
In conclusion, both SM and S infants compared to controls had a greater rate of 
decline in ventilation as well as a greater increase in ventilation in response to a 
hypoxic challenge in the newborn period. Our results also highlight that SM 
infants had a greater magnitude of decline in ventilation than the S infants or 
the controls suggesting that substance misuse and smoking may have an 
additive effect.   
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What is already known on this topic: 
 
 Infants of substance misusing and/or smoking mothers are at increased  
 
risk of SIDS. 
 
 
 
 
What this study adds: 
 
 
 The ventilatory response to a hypoxic challenge was compared in infants 
 
of substance misusing (SM) and smoking (S) mothers and controls. 
 
 The initial increase and magnitude of decline were greater in the SM  
 
Infants. 
 
 The rate of decline was greater in the SM and S infants.  
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Table 1:  Demographics by maternal smoking and substance misuse status 
Data are presented as mean (SD) [median; range]  
 Controls  
(n=19) 
Smoking (S)   
(n=21) 
Substance misuse 
(SM) (n=21) 
Overall p-
value 
Post-hoc tests* 
p- values 
where applicable 
Gestational age 
(wks) 
38.8 (1.7)  
[39; 36-42] 
38.6 (1.7) 
[39; 36-42] 
37.3 (1.6) 
[37; 36-40] 
0.01 S versus control: 0.77 
SM versus S: 0.02 
SM versus control: 0.007 
Birth weight (gms) 3291 (657)  
[3282; 2500-
4972] 
3106 (759) 
[2988; 1860-
4384] 
2536 (487) 
[2465; 1730-3192] 
0.002 S versus control: 0.41 
SM versus S: 0.02 
SM versus control: 0.003 
Head circumference 
(cms) 
34.2 (1.5) 
[35; 32-37] 
34.3 (1.4)  
[35; 32-36] 
33.6 (0.75) 
[34; 32-35] 
0.15  
Maternal age (yrs.) 30.9 (5.1) 
[31; 23-38] 
27.9 (7.8) 
[29; 18-43] 
30.5 (6.2) 
[30; 20-40] 
0.41  
Gender (male) 
 
58% (11) 71% (15) 43% (9) 0.17  
Mode of delivery 
(SVD) 
23% (11) 40% (19) 36% (17) 0.06  
Age at study (days ) 2 (1-5) 2( 1-9) 2(1-8) 0.35  
 
*post-hoc tests only undertaken when the overall comparison of the three groups was statistically significant. 
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Table 2:  Urinary cotinine data by maternal smoking and substance  
misuse status 
Data are expressed as the percentage in each category   
 
   S  SM 
Maternal urine cotinine <10ng/ml 0% 0% 
       10-500ng/ml 40% 23.5% 
        > 500ng/ml 60% 76.5% 
Infant urine cotinine  
        <10ng/ml 
 
0% 
 
0% 
       10-500ng/ml 73% 56% 
       > 500ng/ml 27% 44% 
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Table 3:  Results of the urine analysis of the substance misuse mothers 
 Number 
of  
subjects 
Mean  
(SD) 
Range  
Visits to antenatal clinic and urine 
collected 
20 9.33 (6.8) 1-26 
Number of occasions a particular 
substance was detected  
   
       Methadone  13 6.86 (7.14) 0-26 
       Illicit drug  20 6.95 (4.97) 1-20 
       >1 illicit drug  17 3.95 (2.99) 1-19 
       Ecstasy  6 0.90 (1.29) 0-5 
       Cocaine  13 2.90 (2.84) 0-19 
       Cannabis  11 4.24 (5.01) 0-18 
       Morphine  11 2.19 (2.48) 0-20 
       Any opioid metabolite  11 3.19 (3.68) 0-25 
       Dihydrocodeine  5 0.52 (0.80) 0-3 
       Benzodiazepines  6 0.90 (1.29) 0-6 
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Table 4: Changes in minute ventilation by maternal smoking and substance misuse status  
Data are presented as mean; median (range) 
 Unadjusted values 
mean; median (range) 
Adjusted for gestational age1 
Mean (95% CI) 
 Control  
n=19 
Smoking 
n= 21 
Substance 
misuse  
n=21 
Over-
all P  
Control  
n=19 
Smoking 
(S) 
n= 21 
Substance 
misuse (SM) 
n=21 
Overall P  
P for pairs of means 
Baseline 
minute 
volume 
(ml/kg/min) 
317; 317  
(203-405) 
354; 344  
(253-524) 
416; 408  
(266-614) 
 0.003 
 
 
315  
(283, 350) 
348  
(315, 385) 
395  
(356, 438) 
0.014 
S versus control: 0.16 
SM versus control: 0.005 
SM versus S: 0.10 
Increase in 
minute 
volume 
(ml/kg/min) 
 44; 37 
(0-126) 
55; 45  
(0-163) 
121; 89  
(0-374) 
 0.017 
 
 
47  
(13, 81) 
57  
(25, 89) 
117  
(83, 150) 
0.04 
S versus control: >0.99 
SM versus control: 0.034 
SM versus S: 0.028 
Magnitude of 
decline in 
minute 
volume 
(ml/kg/min) 
100;  102  
(15-233) 
147; 129  
(54-243) 
230; 225  
(56-444) 
 
<0.001 
106  
(70, 142) 
151  
(117, 185) 
220  
(185, 255) 
0.0002 
S versus control: 0.038 
SM versus control: <0.001 
SM versus S: 0.018 
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Rate of 
decline in 
minute 
volume 
(ml/kg/min) 
1.90; 
1.70  
(0.6-5.0) 
7.51;2.58 
(0.59- 
32.17) 
7.21 ;4.64 
(0.10-
31.32) 
0.006 1.60  
(0.98, 2.60) 
3.88  
(2.45, 6.12) 
4.29  
(2.66, 6.92) 
0.009 
S versus control: 0.011 
SM versus control: 0.008 
SM versus S: 0.77 
 
1 Note: adjusted estimates for Increase in minute volume and magnitude of decline in minute volume are calculated from untransformed 
data as confidence intervals based on square root transformed data cannot be back-transformed.  Significance tests are from 
transformed data
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Table 5:  Oxygen saturation by maternal smoking and substance-misuse status.  
Data are presented as median [range] 
 
 Controls 
(n=19) 
Smoking  
(n=21) 
Substance  
(n=21) 
p 
Baseline SpO2 (%)  
 
99 (96-100) 99 (97-100) 100 (96-100) 0.81 
Lowest SpO2 (%) with 
hypoxic challenge 
 
88 (85-94) 88 (85-94) 87 (85-96) 0.65 
Time to lowest SpO2 
(seconds) 
 
115 (60-300) 100 (50-160) 100 (30-200) 0.017 
Change in SpO2 (%)  10 (5-15) 10 (6-15) 11 (4-15) 0.66 
Time to peak minute 
ventilation (seconds) 
94 (10-282) 115 (35-256) 135 (35-286) 0.177 
Maximum baseline end 
tidal CO2 
35 (27-41) 33 (26-42) 31 (27-38) 0.21 
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FIGURE LEGENDS 
 
 
Figure 1: Box plot of the magnitude of decline in minute volume by maternal  
smoking and substance misuse status  
 
 
 
 
 
 
 
 
 
 
 
